These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23703688)

  • 1. Evaluation of VZV-specific cell-mediated immunity in adults infected with HIV-1 by using a simple IFN-γ release assay.
    Watanabe D; Otani N; Suzuki S; Dohi H; Hirota K; Yonemoto H; Koizumi Y; Otera H; Yajima K; Nishida Y; Uehira T; Shima M; Shirasaka T; Okuno T
    J Med Virol; 2013 Aug; 85(8):1313-20. PubMed ID: 23703688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.
    De Castro N; Carmagnat M; Kernéis S; Scieux C; Rabian C; Molina JM
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1089-97. PubMed ID: 21417759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
    Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
    J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
    Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
    J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
    Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
    J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
    Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
    J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity.
    Otani N; Baba K; Okuno T
    J Immunol Methods; 2009 Dec; 351(1-2):71-4. PubMed ID: 19818791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.
    Terada K; Itoh Y; Fujii A; Kitagawa S; Ogita S; Ouchi K
    J Med Virol; 2015 Feb; 87(2):350-6. PubMed ID: 25080078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.
    Shirane R; Tang H; Hayashi K; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
    J Med Virol; 2017 Feb; 89(2):313-317. PubMed ID: 27420414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
    Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
    J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simple-to-Perform
    Boccard M; Conrad A; Mouton W; Valour F; Roure-Sobas C; Frobert E; Rohmer B; Alcazer V; Labussière-Wallet H; Ghesquières H; Venet F; Brengel-Pesce K; Trouillet-Assant S; Ader F
    Front Immunol; 2022; 13():919806. PubMed ID: 35967359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.
    Sadaoka K; Okamoto S; Gomi Y; Tanimoto T; Ishikawa T; Yoshikawa T; Asano Y; Yamanishi K; Mori Y
    J Infect Dis; 2008 Nov; 198(9):1327-33. PubMed ID: 18774884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
    van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
    J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*.
    L'Huillier AG; Ferry T; Courvoisier DS; Aebi C; Cheseaux JJ; Kind C; Rudin C; Nadal D; Hirschel B; Sottas C; Siegrist CA; Posfay-Barbe KM; ; ; ;
    HIV Med; 2012 Jan; 13(1):54-61. PubMed ID: 21722287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.
    Asada H; Nagayama K; Okazaki A; Mori Y; Okuno Y; Takao Y; Miyazaki Y; Onishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Iso H; Yamanishi K;
    J Dermatol Sci; 2013 Mar; 69(3):243-9. PubMed ID: 23183011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community-based survey of varicella-zoster virus-specific immune responses in the elderly.
    Tang H; Moriishi E; Okamoto S; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
    J Clin Virol; 2012 Sep; 55(1):46-50. PubMed ID: 22771002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.
    Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H
    J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.